State University of New York Upstate Medical University

Health System Adoption of LeanTaaS's AI based Capacity Management Solutions Continued to Accelerate in 2021

Retrieved on: 
Monday, December 6, 2021
Software, Technology, General Health, Health, Patient, Yale New Haven Health System, Diagnosis, Health, Cone Health, Seattle Cancer Care Alliance, Executive summary, UCHealth, Paola Lattus, CommonSpirit Health, Michigan Medicine, Technology, Bed, Industry, Time, ORS, Hospital, Surgeon, Partnership, Ambulatory, Executive, Novant Health, Northwestern Memorial Hospital, National Comprehensive Cancer Network, Solution, McLaren Health Care Corporation, National Cancer Institute, COVID-19, Nursing, ROI, Pleasure, State University of New York Upstate Medical University, Twitter, Machine learning, Transform, Silicon, ML, Banner, NCI, Name, LinkedIn, NCCN, Nebraska Medicine, Leadership, Facebook, Growth, Health insurance, Medical imaging, Medical device

Specifically, CommonSpirit Health, one of the largest health systems in the U.S., achieved 14.5x in ROI across 36 hospital locations over a span of 18 months.

Key Points: 
  • Specifically, CommonSpirit Health, one of the largest health systems in the U.S., achieved 14.5x in ROI across 36 hospital locations over a span of 18 months.
  • As we head into 2022, capacity management optimization will continue to be one of the biggest problems facing health systems and hospitals today.
  • LeanTaaSs AI and ML based solutions have now been deployed in more than 475 hospitals across the U.S., including 40% of the top 25 health systems in the country, based on net patient revenue.
  • These health system executives, technology leaders, and industry experts will discuss solutions for the pressing issues facing health systems today.

Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer

Retrieved on: 
Friday, December 3, 2021
Jacobs School of Medicine and Biomedical Sciences, Private Securities Litigation Reform Act, Patient, Risk, EMD, Amathus, Inflammation, Industry, Forward-looking statement, Serono, MD, ATyr Pharma, SEC, Doctor of Philosophy, Foundation, Therapy, Nature, Board of directors, Cirrhosis, Research, Communication, School, State university system, Brandeis University, Marketing, Proteostasis, Biotechnology, Board, Interim, TEL, Acadia Pharmaceuticals, CCL24, Biomedical sciences, Fibrosis, Drug development, State University of New York Upstate Medical University, NASDAQ, Primary sclerosing cholangitis, CMMB, Medical device, Pharmaceutical industry

(NASDAQ: CMMB), (Chemomab) a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced that David M. Weiner, MD has been named Interim Chief Medical Officer, effective immediately.

Key Points: 
  • (NASDAQ: CMMB), (Chemomab) a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced that David M. Weiner, MD has been named Interim Chief Medical Officer, effective immediately.
  • Dr. Aharon intends to continue at Chemomab for the next 60 days and as a senior medical advisor thereafter to ensure a seamless transition.
  • Dr. Weiner most recently served as Chief Executive Officer of Amathus Therapeutics.
  • Previously he was Chief Medical Officer at Lumos Pharma and at aTyr Pharma and, prior to that, he was the Chief Medical Officer and interim Chief Executive Officer of Proteostasis Therapeutics.

Experimental Compound Counters Diabetic Complications

Retrieved on: 
Wednesday, November 24, 2021
Tissue, Patient, DIAPH1, Defense, Swelling, Heart, Cell, Diabetes, Science Translational Medicine, Bacteria, RAGE, MD, End organ damage, Diet, Virus, Drug discovery, Fed, State University of New York Upstate Medical University, Inflammation, Population health, United States Department of Defense, Department, Male, Cytoplasm, DAMPS, Cell death, Pain, Mouse, Muscle tissue, Columbia University Irving Medical Center, Metabolism, Kidney, Kidney bean, Gaps, DNA, Female, Research, Risk, State university system, Columbia University, NYU, Pathology, DAMP, Environmental medicine, Princeton University Department of Chemistry, Immune system, New York University Grossman School of Medicine, Division, Infection, Meal, NYU Langone Health, Plastic surgery, United States Public Health Service, Pharmaceutical industry, Vaccine

NEW YORK, Nov. 24, 2021 /PRNewswire/ -- An experimental compound reduced complications of type 1 and type 2 diabetes in mice not by lowering blood sugar but by countering its consequences: cell death, inflammation, and organ damage.

Key Points: 
  • NEW YORK, Nov. 24, 2021 /PRNewswire/ -- An experimental compound reduced complications of type 1 and type 2 diabetes in mice not by lowering blood sugar but by countering its consequences: cell death, inflammation, and organ damage.
  • The results revolve around the body's immune system, which recognizes and destroys invading bacteria and viruses.
  • Experiments in human cells and mouse models found that the lead study compound, RAGE229, significantly reduced short- and long-term complications of diabetes.
  • The team next incorporated the RAGE229 molecule into mouse chow because dietary intake could better measure its ability to reverse long-term complications like diabetic wounds.

Vallon Pharmaceuticals to Present at the Virtual Investor Roundtable Event

Virtual, ADHD, Central nervous system disease, Narcolepsy, Investor, Round Table, NASDAQ, Department, CNS, Twitter, Company, GLOBE, LinkedIn, Q&A, Interest, Central nervous system, State University of New York Upstate Medical University, Physiology, Patient, Amphetamine, Pharmaceutical industry

PHILADELPHIA, PA, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of central nervous system (CNS) disorders, today announced that David Baker, President and Chief Executive Officer, and Timothy Whitaker, M.D., Chief Medical Officer of Vallon, will participate in the Virtual Investor Roundtable Event on Thursday, November 18, 2021 at 3:00 PM ET.

Key Points: 
  • As part of the virtual event, the Company will provide a brief presentation, followed by a moderated roundtable discussion and an interactive Q&A session.
  • In addition to the moderated portion of the event, all investors and interested parties will have the opportunity to submit questions live during the event.
  • Interested parties may also pre-submit questions in advance of the live event, which can be sent via the conference website at virtualinvestorco.com.
  • A live video webcast of the Roundtable Event will be available on the Events page of the Investors section of the Companys website ( vallon-pharma.com ).

LeanTaaS Announces Transform Hospital Operations Virtual Summit Featuring Keynote from Healthcare Expert Dr. Scott Gottlieb

Retrieved on: 
Wednesday, November 10, 2021
Professional Services, Health, Technology, Hospitals, Insurance, Software, General Health, Industry, American Enterprise Institute, Nebraska Medicine, Hospital, CEO, Northwestern Memorial Hospital, Pfizer, Machine learning, COVID-19, Multimedia, Digital, NEA, Facebook, Yale New Haven Health System, New Enterprise Associates, Commissioner of Food and Drugs, OR, Partnership, AEI, Silicon, Twitter, Paola Lattus, LinkedIn, Solution, UCHealth, Q&A, Transform, CNBC, McLaren Health Care Corporation, EVP, Novant Health, State University of New York Upstate Medical University, Name, Patient, Medicine, Management, Health insurance

Hosted in partnership with Beckers Healthcare , the second Transform will take place from Dec. 7-8, 2021.

Key Points: 
  • Hosted in partnership with Beckers Healthcare , the second Transform will take place from Dec. 7-8, 2021.
  • Dr. Gottliebs session will address key issues facing the healthcare industry, including the urgent need for operational excellence.
  • For up-to-date information on the latest Transform activity, follow LeanTaaS on Twitter and like us on LinkedIn and Facebook for ongoing conference updates.
  • LeanTaaS provides software solutions that combine lean principles, predictive analytics, and machine learning to transform hospital and infusion center operations.

Sports Medicine Primary Care Physician Joins Midwest Orthopaedics at Rush Team

Retrieved on: 
Friday, October 22, 2021
Munster, American Medical Society for Sports Medicine, MD, University, Park Ridge, American Family Physician, State University of New York Upstate Medical University, Chicago Fire FC, Chicago White Sox, Injury, Sports medicine, Dartmouth University, American College of Sports Medicine, Lincoln Park, Rush University, Patient, MOR, Athlete, 1993–94 Chicago Bulls season, No, Chicago Marathon, DePaul University, Joffrey Ballet, Chicago Bulls, Rush, Family medicine, Musculoskeletal injury, Alpha and Omega, U.S. News & World Report, American College, News, American Academy, Rush University Medical Center, Physician, Medical device, Dentistry

CHICAGO, Oct. 22, 2021 /PRNewswire/ -- The primary care sports medicine section at Midwest Orthopaedics at Rush (MOR) is pleased to announce the addition of Caitlin Nicholson, MD to its team of physicians.

Key Points: 
  • CHICAGO, Oct. 22, 2021 /PRNewswire/ -- The primary care sports medicine section at Midwest Orthopaedics at Rush (MOR) is pleased to announce the addition of Caitlin Nicholson, MD to its team of physicians.
  • Dr. Nicholson specializes in the non-surgical treatment of musculoskeletal injuries and has a special interest in the care of endurance athletes.
  • She went on to complete a Primary Care Sports Medicine fellowship at Rush University.
  • During her fellowship at Rush, she served as a team physician for DePaul University, assistant team physician for the Chicago Bulls, Chicago White Sox, and Chicago Steel.

64 Mercy Medical Center Physicians Named Among Region's "TOP DOCTORS" in November 2021 Issue of BALTIMORE Magazine

Retrieved on: 
Thursday, October 21, 2021
State university system, The Sisters of Mercy, University, University of Maryland School of Medicine, State University of New York Upstate Medical University, MBA, Twitter, Maryland School, Gynaecology, Center, Bariatric surgery, Sister, FACS, Weinberg Center, Board, Mercy Hospital, Facebook, Fellow, Health, Self-signed certificate, Physician, Medicine

In addition, Kuldeep Singh, M.D., FACS, MBA, FASMBS, Director of The Maryland Bariatric Center at Mercy, was among several physicians photographed and profiled for the special edition.

Key Points: 
  • In addition, Kuldeep Singh, M.D., FACS, MBA, FASMBS, Director of The Maryland Bariatric Center at Mercy, was among several physicians photographed and profiled for the special edition.
  • Board Certified in Obstetrics and Gynecology, Dr. Taylor earned her medical degree at State University of New York at Buffalo.
  • Founded in 1874 by the Sisters of Mercy, Mercy Medical Center is a university-affiliated hospital with a national reputation for women's health care.
  • Mercy is home to the renowned Weinberg Center for Women's Health and Medicine and the 20-story, $400+ million Mary Catherine Bunting Center.

Kura Oncology Appoints Teresa Bair as Chief Legal Officer

Retrieved on: 
Monday, October 18, 2021
Breakthrough therapy, HNSCC, Tipifarnib, Administration, Bowling Green State University, Cancer, Fortune 500, University, Nasdaq, Senior, State university system, AML, Trustee, Risk, HRAS, NDA, Â, Corporation, Harris Beach, Genomics, University at Buffalo School of Engineering and Applied Sciences, Security (finance), Law, Therapy, Central Waqf Council, FDA, Data analysis, Patient, News, Business administration, Board, GLOBE, KMT2A, U.S. Securities and Exchange Commission, KURA, SAN, Company, NPM1, Drug development, Safety, State University of New York Upstate Medical University, Research, Hand, General counsel, Pharmaceutical industry, Management

SAN DIEGO, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the appointment of Teresa Bair as Chief Legal Officer and Corporate Secretary.

Key Points: 
  • SAN DIEGO, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the appointment of Teresa Bair as Chief Legal Officer and Corporate Secretary.
  • Ms. Bair joins Kura with more than 25 years of combined in-house and law firm experience, most recently as General Counsel at Athenex.
  • On behalf of our board and senior leadership team, we want to extend a warm welcome to Teresa, said Troy Wilson, Ph.D., J.D., President and Chief Executive Officer of Kura Oncology.
  • Ms. Bair joins Kura from Athenex, where she served most recently as General Counsel and Senior Vice President, Administration.

Susan J. Littman, M.D., is recognized by Continental Who's Who as a Trusted Internist in the field of Medicine in recognition of her role as Hematologist and Oncologist at Crozer Medical Center

Retrieved on: 
Thursday, October 14, 2021
Wilms' tumor, Duke University, Organization, Albany Medical College, Hematology, Liver, State university system, Gardening, Bachelor, Molecular biology, Woman, University of Texas Southwestern Medical Center, Internal medicine, Biliary tract, Master, Multimedia, Medicine, Pancreas, Public health, Botany, National Association, International Association, Hematology-Oncology and Stem Cell Transplantation Research Center, National, NAPW, Cornell University, Duke, State University of New York Upstate Medical University

AMBLER, Pa., Oct. 14, 2021 /PRNewswire/ -- Established since 1990, Crozer Medical Center is a locally and nationally serving medical entity that is well regarded for its extraordinary medical practices.

Key Points: 
  • AMBLER, Pa., Oct. 14, 2021 /PRNewswire/ -- Established since 1990, Crozer Medical Center is a locally and nationally serving medical entity that is well regarded for its extraordinary medical practices.
  • A patient-centered facility, Crozer Medical is a leader in the healthcare community.
  • With over twenty-two illustrious years of experience in the field of medicine, Dr. Susan J. Littman is revered for her outstanding contributions to the profession.
  • She completed an internship and residency in Internal Medicine at UT Southwestern and a fellowship in Hematology/Oncology at Duke.

Braxia Scientific CEO Dr. Roger McIntyre to Share Stage With NBA Champion Lamar Odom and 'Psychedelic Concierge' Zappy Zapolin to Discuss the Benefits of Ketamine Treatment for Mental Health

Retrieved on: 
Thursday, October 14, 2021
Risk, Pharmacology, Telehealth, FWB, Adrienne Arsht Center for the Performing Arts, State University of New York, Korea University, Lists of diseases, SUNY, State University of New York Upstate Medical University, Ketamine, State university system, Ta' Braxia Cemetery, CSE, OTC, Depression, Drug prohibition law, Ibogaine, PTSD, Guangzhou Medical University, Meditation, Addiction, The New York Times, FDA, Multimedia, News, Removal of cannabis from Schedule I of the Controlled Substances Act, University, CDSA, Health Canada, Clarivate, Forward-looking statement, Company, National Basketball Association, Psychiatry, College, Transitive dependency, Person, Controlled Drugs and Substances Act, Psilocybin, Anxiety, Euro-Excellence Inc v Kraft Canada Inc, Disorder, Rapids, Consciousness, Pharmaceutical industry, Audit

As a world-leading depression researcher, Dr. Roger McIntyre has been named one of the world's most influential scientific minds by Clarivate for seven consecutive years.

Key Points: 
  • As a world-leading depression researcher, Dr. Roger McIntyre has been named one of the world's most influential scientific minds by Clarivate for seven consecutive years.
  • Lamar Odom is a two-time National Basketball Association champion, Olympic gold medalist, New York Times bestselling author, and mental health advocate.
  • Zappy Zapolin is the co-founder and executive chairman of KetaMD , a developing telemedicine platform that provides at-home medical ketamine treatments.
  • "Dr. McIntyre and I are very mission-aligned on the untapped benefits of psychedelics in the treatment of many mental health conditions," says Zappy Zapolin, co-founder of KetaMD and director of Reborn.